Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 6Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Radiomics × Clear all
NCT03917017 2022-02-15

The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular Carcinoma

Zhujiang Hospital

Phase NA Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03979573 2019-06-07

PROMM-AS

Heinrich-Heine University, Duesseldorf

Phase NA Unknown
90 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡